Rare diseases
Investigational molecules
Locations
Back to France2 623 clinical trials in Paris, France across 36 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Long-term Safety and Effects of ARGX-117 for Adults with Multifocal Motor Neuropathy
FranceStudy on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery
FranceLong-term Study on the Safety and Effectiveness of Odevixibat for Patients with Alagille Syndrome
FranceStudy on Bepranemab for Patients with Early Alzheimer's Disease
FranceStudy of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma
FranceStudy of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery
FranceFranceStudy of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure
FranceStudy of Bosutinib for Children with Newly Diagnosed or Resistant Chronic Myeloid Leukemia
FranceStudy on the Effectiveness and Safety of Cyclophosphamide Monohydrate and Drug Combination for Patients with Persistent or Recurrent Rare Epithelial Ovarian Tumors
FranceStudy of BDC-1001 and Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer Previously Treated with Trastuzumab Deruxtecan
FranceStudy of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on head and neck squamous cell carcinoma and endometrial cancer, evaluating innovative treatment combinations and survival outcomes.
Clinical investigations targeting Type 1 Diabetes and obesity, with novel therapeutic approaches using tirzepatide for improved glycemic control.
Innovative vaccine trials for COVID-19, influenza, and cytomegalovirus, exploring both intranasal and injectable delivery methods.
Advanced research in multiple sclerosis and Alzheimer's disease, utilizing cutting-edge imaging techniques to study neuroinflammation and synaptic density.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
